Craig Roberts
North Wales, United States
Craig Roberts is currently Associate Vice President for the Center for Observational and Real-world Evidence (CORE) Vaccines Product Line within Merck Research Labs. In this role he leads a research team that designs and conducts observational research studies to characterize the public health and economic burden of vaccine preventable diseasesglobally. The team develops data to simulate the impact of Merck vaccines on disease, and applies these data to communicate the value of vaccines to public health decision makers. Prior to joining Merck, Dr Roberts was leading the health economic and outcomes research team supporting Global Vaccines and Consumer Products for Pfizer Inc. During his tenure at Pfizer, he made significant contributions defining the value proposition of several key products globally, including Zithromax, Vfend, Norvasc, Lipitor, Caduet, and Prevenar 13. Prior to joining Pfizer, Dr. Roberts led outcomes research operations at NDCHealth, where he was responsible for the design, conduct, and publication of analyses from large US healthcare databases. Dr. Roberts has co-authored numerous publications in peer-reviewed journals including Vaccine, Stroke, CHEST, Value in Health, and Pharmacoeconomics. He earned his PharmD and MPA degrees from the University of Kentucky, received an MBA from New York University, and completed a fellowship in health economics through GlaxoSmithKline and Thomas Jefferson University in Philadelphia.
Last updated:
For AI agents: llms.txt
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
How do I contact Craig Roberts?
Public channels for Craig Roberts include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
